2Grajewska M,Sulikowska B,Manitius J.Torasaide (TrifaS)in clini-cal practice owe ence[].Przeglad Lekarski.2003
3Brater DC.Clinical pharmacology of loop diuretics[].Drugs.
4Munchen,FRG.Swelling of glial cells in lactacidosis and by glutamate sig-nificance of Cl (—)-transport[].Brain Research.1993
二级参考文献6
1Abecasis R, Guevara M, Miguez C, et al. Long-term efficacy of torasemide compared with furosemide in hepatic cirrhotic patients with ascites. Scand J Gastroenterol, 2001,36:309-313.?A
2Fortuno A, Muniz P, Ravassa S, et al. Torasemide inhibits angiotensin Ⅱ-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats. Hypertension, 1999,34:138.
3Cosin J, Diez J, TORIC investigators. Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail,2002,4: 507-513.
4Muller K, Gamba G, Jaquet F, et al. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA Ⅱ to Ⅳ--efficacy and quality of life. Eur J Heart Fail, 2003,5:793-801.
5Vasavada N, Saha C, Agarwal R. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.Kidney Int, 2003,64: 632-640.
